| Literature DB >> 33383855 |
Pietro Crispino1, Miriam Gino2, Elena Barbagelata3, Tiziana Ciarambino4, Cecilia Politi5, Immacolata Ambrosino6, Rosalia Ragusa7, Marina Marranzano8, Antonio Biondi9, Marco Vacante9.
Abstract
Parkinson's disease has been found to significantly affect health-related quality of life. The gender differences of the health-related quality of life of subjects with Parkinson's disease have been observed in a number of studies. These differences have been reported in terms of the age at onset, clinical manifestations, and response to therapy. In general, women with Parkinson's disease showed more positive disease outcomes with regard to emotion processing, non-motor symptoms, and cognitive functions, although women report more Parkinson's disease-related clinical manifestations. Female gender predicted poor physical functioning and socioemotional health-related quality of life, while male gender predicted the cognitive domain of health-related quality of life. Some studies reported gender differences in the association between health-related quality of life and non-motor symptoms. Depression and fatigue were the main causes of poorer health-related quality of life in women, even in the early stages of Parkinson's disease. The aim of this review was to collect the best available evidence on gender differences in the development of Parkinson's disease symptoms and health-related quality of life.Entities:
Keywords: Parkinson’s disease; dopamine; gender; levodopa; quality of life
Mesh:
Year: 2020 PMID: 33383855 PMCID: PMC7795924 DOI: 10.3390/ijerph18010198
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390